Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

: A Phase III Multicenter, Randomized, Parallel Group, Controlled, Double Blind Study to Investigate the Safety and Efficacy of Inhaled Mannitol Over 12 Months in the Treatment of Bronchiectasis.

NCT00669331 is registered in ClinicalTrials.gov with Syntara as lead sponsor.

NCT NCT00669331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00669331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
: A Phase III Multicenter, Randomized, Parallel Group, Controlled, Double Blind Study to Investigate the Safety and Efficacy of Inhaled Mannitol Over 12 Months in the Treatment of Bronchiectasis.
Lead sponsor
Syntara
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2009
Completion date
January 31, 2014
Enrollment
485 (actual)
Sites
83

Conditions

As the registry lists them; a condition with its own page is linked.

bronchiectasis